Abstract:The International Agency for Research on Cancer has classified several antineoplastic drugs in Group 1 (human carcinogens), among which chlorambucil, cyclophosphamide (CP) and tamoxifen, Group 2A (probable human carcinogens), among which cisplatin, etoposide, N-ethyl- and N-methyl-N-nitrosourea, and Group 2B (possible human carcinogens), among which bleomycins, merphalan and mitomycin C. The widespread use of these mutagenic/carcinogenic drugs in the treatment of cancer has led to anxiety about possible genoto… Show more
“…In this paper, we report the results of a biological effect monitoring study performed to complete the assessment of genetic effects of exposure to environmental genotoxins in a group of health-care workers occupationally exposed to ANPDs. The frequency of MNs was evaluated in PBLs of subjects also monitored for primary DNA damage by the comet assay 23) . The alkaline comet assay detects primary DNA lesions (e.g., DNA double-and single-strand breaks, alkali-labile sites such as apurinic/apyrimidinic sites and incomplete excision repair sites) present in leukocytes (or lymphocytes) at the time of blood sampling 29) .…”
Section: Discussionmentioning
confidence: 99%
“…The results indicated no exposure-related excess of MNs in exposed subjects compared with controls, despite the occurrence of detectable environmental Table 4. Frequency of MNs per 1,000 binucleated lymphocytes and CBPI in nurses exposed to antineoplastic drugs and nonexposed subjects with respect of gender, age and smoking habits (whole population) and occupational assignment, job seniority and personal protection (exposed subjects) contamination by 5-fluorouracil (5FU) and cytarabine (CYT) on selected surfaces (wipes) and on the exposed nurses' clothes (pads) 23) . Similar to our findings, negative results for MN induction were reported in other investigations on workers exposed to ANPDs 11−15) .…”
Section: Discussionmentioning
confidence: 99%
“…Similar to our findings, negative results for MN induction were reported in other investigations on workers exposed to ANPDs 11−15) . As reported previously 23) , healthcare workers handling ANPDs were evaluated for genotoxic damage in peripheral blood leukocytes, and primary DNA damage was evaluated by applying the comet assay for detecting early biological effects of DNA-damaging agents (i.e., antineoplastic drugs). We found higher DNA migration extents in the exposed subjects when compared with the controls.…”
Section: Discussionmentioning
confidence: 99%
“…In a previously published paper 23) , we reported the results of DNA damage (assessed by the alkaline comet assay) in peripheral blood leukocytes of workers handling ANPDs; the levels of environmental exposure were evaluated by the wipe test and the degree of skin exposure by pads; the determination of urinary cyclophosphamide was also used as an indicator of biological uptake of specific ANPDs. On average, analysis of contamination in the work environment showed the presence of trace amounts of ANPDs, and urine samples were positive for cyclophosphamide in about 13% of the workers.…”
Biological Effect Monitoring in Peripheral Blood Lymphocytes from Subjects Occupationally Exposed to Antineoplastic Drugs: Assessment of Micronuclei Frequency: Milena VILLARINI, et al. Department of Medical‐Surgical Specialties and Public Health (Section of Public Health), University of Perugia, Italy—
Objectives
Antineoplastic drugs (ANPDs) are widely used in the treatment of cancer and some nonneoplastic diseases. However, most if not all of these chemical agents are generally nonselective and, along with tumor cells, normal cells may undergo cytotoxic/genotoxic damage. Italian pharmacists and nurses occupationally exposed to ANPDs during their normal work routines were monitored to evaluate biological effects (i.e., cytogenetic damage) eventually associated with exposure. The subjects were also monitored for primary, oxidative and excision repaired DNA damage as evaluated by comet assay (published data). In the present paper, we present the results obtained with the cytokinesis‐block micronucleus (CBMN) test.
Methods
The CBMN test in peripheral blood lymphocytes was applied because of its ability to detect both clastogenic and aneugenic effects, and because it has recently been reported that micronuclei (MNs) are predictive of cancer risk in human populations. In this study, the evaluation of MN frequency was carried out using the CBMN test in the absence or in the presence of the DNA repair inhibitor Ara‐C (cytosine arabinoside).
Results
No significant difference was observed for MN frequency comparing nurses handling ANPDs (exposed subjects) and controls; no correlations were found between job seniority, age, smoking habits and MN rates.
Conclusions
Concerning the aim of this study to evaluate the genotoxic risk arising from occupational exposure to ANPDs, statistically significant differences in MN rates in the subjects under study could not be determined.
“…In this paper, we report the results of a biological effect monitoring study performed to complete the assessment of genetic effects of exposure to environmental genotoxins in a group of health-care workers occupationally exposed to ANPDs. The frequency of MNs was evaluated in PBLs of subjects also monitored for primary DNA damage by the comet assay 23) . The alkaline comet assay detects primary DNA lesions (e.g., DNA double-and single-strand breaks, alkali-labile sites such as apurinic/apyrimidinic sites and incomplete excision repair sites) present in leukocytes (or lymphocytes) at the time of blood sampling 29) .…”
Section: Discussionmentioning
confidence: 99%
“…The results indicated no exposure-related excess of MNs in exposed subjects compared with controls, despite the occurrence of detectable environmental Table 4. Frequency of MNs per 1,000 binucleated lymphocytes and CBPI in nurses exposed to antineoplastic drugs and nonexposed subjects with respect of gender, age and smoking habits (whole population) and occupational assignment, job seniority and personal protection (exposed subjects) contamination by 5-fluorouracil (5FU) and cytarabine (CYT) on selected surfaces (wipes) and on the exposed nurses' clothes (pads) 23) . Similar to our findings, negative results for MN induction were reported in other investigations on workers exposed to ANPDs 11−15) .…”
Section: Discussionmentioning
confidence: 99%
“…Similar to our findings, negative results for MN induction were reported in other investigations on workers exposed to ANPDs 11−15) . As reported previously 23) , healthcare workers handling ANPDs were evaluated for genotoxic damage in peripheral blood leukocytes, and primary DNA damage was evaluated by applying the comet assay for detecting early biological effects of DNA-damaging agents (i.e., antineoplastic drugs). We found higher DNA migration extents in the exposed subjects when compared with the controls.…”
Section: Discussionmentioning
confidence: 99%
“…In a previously published paper 23) , we reported the results of DNA damage (assessed by the alkaline comet assay) in peripheral blood leukocytes of workers handling ANPDs; the levels of environmental exposure were evaluated by the wipe test and the degree of skin exposure by pads; the determination of urinary cyclophosphamide was also used as an indicator of biological uptake of specific ANPDs. On average, analysis of contamination in the work environment showed the presence of trace amounts of ANPDs, and urine samples were positive for cyclophosphamide in about 13% of the workers.…”
Biological Effect Monitoring in Peripheral Blood Lymphocytes from Subjects Occupationally Exposed to Antineoplastic Drugs: Assessment of Micronuclei Frequency: Milena VILLARINI, et al. Department of Medical‐Surgical Specialties and Public Health (Section of Public Health), University of Perugia, Italy—
Objectives
Antineoplastic drugs (ANPDs) are widely used in the treatment of cancer and some nonneoplastic diseases. However, most if not all of these chemical agents are generally nonselective and, along with tumor cells, normal cells may undergo cytotoxic/genotoxic damage. Italian pharmacists and nurses occupationally exposed to ANPDs during their normal work routines were monitored to evaluate biological effects (i.e., cytogenetic damage) eventually associated with exposure. The subjects were also monitored for primary, oxidative and excision repaired DNA damage as evaluated by comet assay (published data). In the present paper, we present the results obtained with the cytokinesis‐block micronucleus (CBMN) test.
Methods
The CBMN test in peripheral blood lymphocytes was applied because of its ability to detect both clastogenic and aneugenic effects, and because it has recently been reported that micronuclei (MNs) are predictive of cancer risk in human populations. In this study, the evaluation of MN frequency was carried out using the CBMN test in the absence or in the presence of the DNA repair inhibitor Ara‐C (cytosine arabinoside).
Results
No significant difference was observed for MN frequency comparing nurses handling ANPDs (exposed subjects) and controls; no correlations were found between job seniority, age, smoking habits and MN rates.
Conclusions
Concerning the aim of this study to evaluate the genotoxic risk arising from occupational exposure to ANPDs, statistically significant differences in MN rates in the subjects under study could not be determined.
RESUMENIntroducción: Son muchos los riesgos laborales a los que están expuestos los trabajadores de salud que manipulan quimioterápicos.Objetivos: Identificar y describir los daños a corto, medio y largo plazo, causados en el organismo de los enfermeros y otros profesionales de la salud, que están expuestos a los fármacos antineoplásicos en el lugar de trabajo.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.